136 related articles for article (PubMed ID: 6571800)
1. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
2. Changes of prekallikrein in the cases with disseminated intravascular coagulation syndrome.
Sakuragawa N; Takahashi K; Shibata A
Adv Exp Med Biol; 1979; 120B():185-93. PubMed ID: 160191
[TBL] [Abstract][Full Text] [Related]
3. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
4. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis in patients with acute promyelocytic leukemia and disseminated intravascular coagulation during heparin therapy.
Imaoka S; Ueda T; Shibata H; Masaoka T; Ogawa M; Sasaki Y; Iwanaga T; Terasawa T
Cancer; 1986 Oct; 58(8):1736-8. PubMed ID: 2428461
[TBL] [Abstract][Full Text] [Related]
6. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia.
Asakura H; Saito M; Ito K; Jokaji Y; Uotani C; Kumabashiri I; Matsuda T
Thromb Res; 1988 Jun; 50(6):895-9. PubMed ID: 3166241
[No Abstract] [Full Text] [Related]
7. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
Castaman G; Ruggeri M; Rodeghiero F
Thromb Res; 1989 Sep; 55(5):661-4. PubMed ID: 2814948
[No Abstract] [Full Text] [Related]
8. Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid Org 10172.
Nieuwenhuis HK; Sixma JJ
Cancer; 1986 Aug; 58(3):761-4. PubMed ID: 2425925
[TBL] [Abstract][Full Text] [Related]
9. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
Tomihara T; Shimazu C; Yasuda K; Kazama M; Abe T
Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
[No Abstract] [Full Text] [Related]
10. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
Braunstein KM; Eurenius K
Am J Clin Pathol; 1976 Sep; 66(3):488-94. PubMed ID: 60879
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
von Kries R; Stannigel H; Göbel U
Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
[TBL] [Abstract][Full Text] [Related]
12. The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):623-7. PubMed ID: 1664251
[TBL] [Abstract][Full Text] [Related]
13. [Heparin as treatment for hypercoagulability syndrome in a case of acute promyelocytic leukemia].
Pizzuto J; Gonzalez Llaven J; Uribe Cortes JA
Sangre (Barc); 1969; 14(3):363-70. PubMed ID: 5288844
[No Abstract] [Full Text] [Related]
14. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
[TBL] [Abstract][Full Text] [Related]
15. Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia.
Sterrenberg L; Haak HL; Brommer EJ; Nieuwenhuizen W
Haemostasis; 1985; 15(2):126-33. PubMed ID: 3859461
[TBL] [Abstract][Full Text] [Related]
16. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
Wisecarver JL; Haire WD
Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
[TBL] [Abstract][Full Text] [Related]
17. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
18. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of disseminated intravascular coagulation].
Asakura H
Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
[TBL] [Abstract][Full Text] [Related]
20. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?
Goldberg MA; Ginsburg D; Mayer RJ; Stone RM; Maguire M; Rosenthal DS; Antin JH
Blood; 1987 Jan; 69(1):187-91. PubMed ID: 3466655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
